Hospital management company Universal Health Services (NYSE: UHS) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 8.3% year on year to $4.64 billion. The company’s full-year revenue guidance of $18.63 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $5.98 per share was in line with analysts’ consensus estimates.

Is now the time to buy Universal Health Services? Find out by accessing our full research report, it’s free.

Company Overview

With a network spanning 39 states and three countries, Universal Health Services (NYSE: UHS) operates acute care hospitals and behavioral health facilities across the United States, United Kingdom, and Puerto Rico.

Revenue Growth

A company’s long-term sales performance can indicate its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Luckily, Universal Health Services’s sales grew at a decent 8.2% compounded annual growth rate over the last five years. Its growth was slightly above the average healthcare company and shows its offerings resonate with customers.

We at StockStory place the most emphasis on long-term growth, but within healthcare, a half-decade historical view may miss recent innovations or disruptive industry trends. Universal Health Services’s annualized revenue growth of 9.8% over the last two years is above its five-year trend, suggesting some bright spots.

We can better understand the company’s revenue dynamics by analyzing its same-store sales, which show how much revenue its established locations generate. Over the last two years, Universal Health Services’s same-store sales averaged 4.2% year-on-year growth. Because this number is lower than its revenue growth, we can see the opening of new locations is boosting the company’s top-line performance.

This quarter, Universal Health Services reported year-on-year revenue growth of 8.3%, and its $4.64 billion of revenue exceeded Wall Street’s estimates by 1.1%.

Looking ahead, sell-side analysts expect revenue to grow 4.5% over the next 12 months, a deceleration versus the last two years. This projection is underwhelming and suggests its products and services will face some demand challenges.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.

Adjusted Operating Margin

Adjusted operating margin is one of the best measures of profitability because it tells us how much money a company takes home after subtracting all core expenses, like marketing and R&D. It also removes various one-time costs to paint a better picture of normalized profits.

Universal Health Services was profitable over the last five years but held back by its large cost base. Its average adjusted operating margin of 9.8% was weak for a healthcare business.

On the plus side, Universal Health Services’s adjusted operating margin rose by 3.1 percentage points over the last five years, as its sales growth gave it operating leverage. Zooming in on its more recent performance, we can see the company’s trajectory is intact as its margin has also increased by 1.9 percentage points on a two-year basis.

In Q2, Universal Health Services generated an adjusted operating margin profit margin of 11.6%, in line with the same quarter last year. This indicates the company’s overall cost structure has been relatively stable.

Earnings Per Share

We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.

Universal Health Services’s EPS grew at 12.8% compounded annual growth rate over the last five years, higher than its 8.2% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded.

We can take a deeper look into Universal Health Services’s earnings to better understand the drivers of its performance. As we mentioned earlier, Universal Health Services’s adjusted operating margin was flat this quarter but expanded by 3.1 percentage points over the last five years. On top of that, its share count shrank by 30%. These are positive signs for shareholders because improving profitability and share buybacks turbocharge EPS growth relative to revenue growth.

In Q2, Universal Health Services reported adjusted EPS of $5.98, up from $5.35 in the same quarter last year. This print was close to analysts’ estimates. Over the next 12 months, Wall Street expects Universal Health Services’s full-year EPS to grow 4.3% from $23.17 to $24.18.

Key Takeaways from Universal Health Services’s Q2 Results

It was good to see Universal Health Services narrowly top analysts’ revenue expectations this quarter. We were also glad its full-year revenue guidance slightly exceeded Wall Street’s estimates. On the other hand, its full-year EPS guidance missed and its full-year EBITDA guidance fell slightly short of Wall Street’s estimates. Overall, this was a softer quarter. The stock traded down 7.3% to $147.55 immediately following the results.

Is Universal Health Services an attractive investment opportunity right now? We think that the latest quarter is only one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).